These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Mechanisms of experimental hematogenous metastasis and its dependence on the reactive defense in the host organism]. Arnold W; Graffi A Z Exp Chir; 1974; 7(4):216-27. PubMed ID: 4440031 [No Abstract] [Full Text] [Related]
7. Tumor immunity following cryosurgery or electrocauterization. Bagley DH; Faraci RP Natl Cancer Inst Monogr; 1978 Dec; (49):371-3. PubMed ID: 748796 [TBL] [Abstract][Full Text] [Related]
8. In vitro demonstration of cryosurgical augmentation of tumor immunity. Faraci RP; Bagley DH; Marrone J; Beazley RM Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499 [TBL] [Abstract][Full Text] [Related]
9. [Development of a cryogenic system and tools for surgery and therapy]. Danichenko MIu Med Tekh; 2007; (6):24-7. PubMed ID: 18274102 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery. Shibata T; Yamashita T; Suzuki K; Takeichi N; Micallef M; Hosokawa M; Kobayashi H; Murata M; Arisue M Anticancer Res; 1998; 18(6A):4443-8. PubMed ID: 9891507 [TBL] [Abstract][Full Text] [Related]
11. Immunogenic efficacy of various syngeneic tumor cell preparations. Natale N; Reiner J; Southam CM Cancer; 1971 Nov; 28(5):1118-25. PubMed ID: 5125660 [No Abstract] [Full Text] [Related]
12. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection. Leffell MS; Coggin JH Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044 [No Abstract] [Full Text] [Related]
13. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity. Kearney R; Nelson DS Aust J Exp Biol Med Sci; 1973 Dec; 51(6):723-35. PubMed ID: 4788454 [No Abstract] [Full Text] [Related]
14. Cryosurgery for the treatment of cancer. Neel HB Laryngoscope; 1980 Aug; 90(8 Pt 2):1-48. PubMed ID: 6995752 [TBL] [Abstract][Full Text] [Related]
15. Cyclophosphamide pretreatment in tumor cryotherapy: a comparison with alternative drugs. Cooper AJ; Fraser JD Cryobiology; 1983 Feb; 20(1):78-82. PubMed ID: 6831912 [TBL] [Abstract][Full Text] [Related]
16. Rank order of sarcoma susceptibility among mouse strains reverses with low concentrations of carcinogen. Prehn LM; Lawler EM Science; 1979 Apr; 204(4390):309-10. PubMed ID: 432644 [TBL] [Abstract][Full Text] [Related]
17. [Cryogenic device for local freezing and irrigation]. Voĭtyna SV; Pisarevskiĭ AA; Shirokikh GN; Evstifeev EA Med Tekh; 1976; (5):26-8. PubMed ID: 1027967 [No Abstract] [Full Text] [Related]
18. Cryonecrosis of normal and tumor-bearing rat liver potentiated by inflow occlusion. Neel HB; Ketcham AS; Hammond WG Cancer; 1971 Nov; 28(5):1211-8. PubMed ID: 5125668 [No Abstract] [Full Text] [Related]
19. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice. Vaage J Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179 [No Abstract] [Full Text] [Related]
20. Resting energy expenditure of host and tumor is similar in rats with methylcholanthrene-induced sarcoma. Freund HR; Kim MW; Muggia-Sullam M; Chance WT; Fischer JE Arch Surg; 1987 Oct; 122(10):1151-2. PubMed ID: 3662795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]